ARK Genomic Revolution ETF (ARKG), issued by ARK, reported 33 long positions and $1.6B in net assets in its Jul 2026 N-PORT filing. The ten largest positions account for 59.05% of net assets.
Reporting period: 31 Jul 2026 · 9 filings on file · N-PORT is filed monthly and published quarterly, roughly 60 days in arrears
Net assets
$1.6B
As of Jul 2026
Positions
33
Long positions in the filing
Top 10 weight
59.05%
Top 25: 94.17%
Effective holdings
21
Concentrated
Cash
0.00%
Share of net assets
Securities on loan
23.9722%
17 positions on loan
Sector exposure
3 sectors · Jul 2026
Health Care75.27%
Technology24.55%
Funds0.18%
Ten largest holdings
Top 10 of 33 positions · Jul 2026
Ten largest holdings reported by ARKG as of 31 Jul 2026
#
Security
CUSIP
Value
% of net assets
1
10X GENOMICS INC-CLASS A
88025U109
$146.3M
9.39%
2
TWIST BIOSCIENCE CORP
90184D100
$120.4M
7.73%
3
TEMPUS AI INC-CL A
88023B103
$102.2M
6.56%
4
CRISPR THERAPEUTICS AG
000000000
$97.9M
6.29%
5
PERSONALIS INC
71535D106
$85.3M
5.47%
6
ABSCI CORP
00091E109
$80.0M
5.14%
7
GUARDANT HEALTH INC
40131M109
$73.8M
4.74%
8
ILLUMINA INC
452327109
$73.8M
4.74%
9
ELI LILLY & CO
532457108
$73.0M
4.68%
10
CAREDX INC
14167L103
$66.9M
4.30%
Full holdings, position changes between periods, fund overlap, cross-fund crowding and securities lending detail for ARKG are in the ETF X-Ray dashboard.